Home / Medical Devices / Orthobiologics Market By Product Type (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate), By Application (Osteoarthritis And Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial And Dental Applications) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Orthobiologics Market By Product Type (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate), By Application (Osteoarthritis And Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial And Dental Applications) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: Aug 2018 | Report Code: 59292-08-18

Industry Outlook

The global orthobiologics market to reach US$ 8,136.9 Mn in 2026 and projected to exhibit a compound annual growth rate (CAGR) of 5.7% during the forecast period from 2018 to 2026. Orthobiologics refer to biologics and cellular therapies in orthopedics made of range of products such as recombinant growth factors, bone void fillers, stem cells and grafts. Orthobiologics has evolved in the last two decade resulting in significant role in modern orthopedic surgeries and therapies. Extensive understanding of stem cells and, biological growth factors in the healing process of musculoskeletal injuries, bone regeneration, tendon and ligament repair has stimulated the application of orthobiologics in various orthopedic ailments. The various products in orthobiologics include platelet rich plasma (PRP), stem cells, bone grafts, autologous conditioned serum and growth factors. There is a growing uptake of orthobiologics in sports medicine owing to its lower side effects and shorter recovery time. PRP has demonstrated promising results in treatment of tendonopathies in adults and is being used as an aide in other sports injury treatment. Other orthopedic application of orthobiologics in sports medicines include ACL rupture treatment, cartilage damage, among others. According to Centers for Disease Control and Prevention (CDC), more than 3.5 million children below age 14 receive medical treatment for sports injuries each year in U.S. alone. Thus, growing sports injuries is a major driver for the growth of orthobiologics market. As orthobiologics treatment are in nascent stage, the treatment cost is higher as compared to traditional invasive therapies. Moreover, lower insurance coverage for orthobiologics would further hinder the market growth in the developing nations.

Market Synopsis

Orthobiologics Market

Osteoarthritis Prevalence to Drive Orthobiologics Market

In 2017, osteoarthritis and degenerative arthritis held the largest share in the global orthobiologics market owing to rise in target population suffering from degenerative arthritis, growing public awareness regarding side effects of continuous oral medications, and introduction of products with better clinical outcome in osteoarthritis management. Spinal fusion segment is projected to exhibit fastest growth rate during the forecast period owing to increase in the number of spinal fusion surgeries globally. American Academy of Orthopedic Surgeons (AAOS) suggests that a total of 0.46 million spinal fusion surgeries was performed in U.S. in 2011. Advent of minimally invasive surgeries have further boosted the successful outcomes of spinal surgeries. Demand for bone grafts and stem cells have soared high owing to the growing number of orthopedic procedures; consequently driving the orthobiologics market.

Orthobiologics Market

North America Held the Pole Position in Global Orthobiologics Market

In 2017, North America held the largest share in the global orthobiologics market due to factors such as developed healthcare facilities, patient awareness towards biologics and minimally invasive surgeries, affordability towards expensive therapies and growing research and development of orthobiologics for various orthopedic disorders. Moreover, growing prevalence of obesity and high population of baby boomer susceptible for orthopedic degenerative ailments further boost the orthobiologics market. As per the CDC Report 2015, osteoarthritis affects approximately 30 million U.S. adult population. Asia Pacific is projected to grow at fastest growth rate owing to budding biopharmaceutical and medical devices companies, government initiatives to develop the healthcare infrastructure, flourishing medical tourism industry in countries such as India, Thailand and Indonesia. Large patient pool and growing geriatric population in Japan and China further boosts the demand for orthobiologics market.

Orthobiologics Market

Historical & Forecast Period

2016 – Historical Year

2017 – Base Year

2018-2026 – Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.

Orthobiologics Market

Report Scope by Segments

Orthobiologics market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product type, application and geography.

By Product Type (2016–2026; US$ Mn)

  • Viscosupplementation Products
  • Demineralized Bone Matrices
  • Synthetic Orthobiologics
  • Bone Morphogenic Protein
  • Allografts
  • Plasma-Rich Protein
  • Bone Marrow Aspirate Concentrate

By Application Type (2016–2026; US$ Mn)

  • Osteoarthritis and Degenerative Arthritis
  • Spinal Fusion
  • Soft-Tissue Injuries
  • Fracture Recovery
  • Maxillofacial and Dental Applications

Geography Segment (2016–2026; US$ Mn)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • GCC
    • Rest of Middle East and Africa

Market is studied in order to understand the current and future market trends in the orthobiologics market. The market is estimated by providing the compounded annual growth rate (CAGR) and data forecast from 2018 to 2026. Strategic merger, acquisition and collaboration among the key players for developing innovative product pipeline mentioned in the business strategy section. The key players currently engaged in the orthobiologics market are DePuy Synthes, Stryker Corporation, Medtronic plc, NuVasive Inc., Zimmer Biomet, Globus Medical, Inc., Orthofix Internamtional NV, Harvest Technologies Corporation, Seaspine Holdings Corporation, RTI Surgicals among others.

Key questions answered in this report

  • How the global orthobiologics market will perform during the forecast period from 2018 to 2026?
  • What are the latest trends in the orthobiologics market and valuable opportunities for key players?
  • Who are the leading players in the global orthobiologics market?
  • Which is the leading/and fastest region in the global orthobiologics market?
  • Currently, what are the reimbursement scenario and regulatory structure for the orthobiologics?
  • What are drivers and restrains governing the global orthobiologics market?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Orthobiologics Market Portraiture
2.2. Global Orthobiologics Market, by Product Type, 2017 (US$ Mn)
2.3. Global Orthobiologics Market, by Application, 2017 (US$ Mn)
2.4. Global Orthobiologics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Orthobiologics: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Orthobiologics Market, by Key Players, 2017

Chapter 4. Global Orthobiologics Market, by Product Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Viscosupplementation Products
4.3. Demineralized Bone Matrices
4.4. Synthetic Orthobiologics
4.5. Bone Morphogenic Protein
4.6. Allografts
4.7. Plasma-Rich Protein
4.8. Bone Marrow Aspirate Concentrate

Chapter 5. Global Orthobiologics Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Osteoarthritis and Degenerative Arthritis
5.3. Spinal Fusion
5.4. Soft-Tissue Injuries
5.5. Fracture Recovery
5.6. Maxillofacial and Dental Applications

Chapter 6. Global Orthobiologics Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Orthobiologics Market Analysis, 2016 – 2026
6.1.1. North America Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.1.2. North America Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.1.3. North America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe Orthobiologics Market Analysis, 2016 – 2026
6.2.1. Europe Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.2.3. Europe Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific Orthobiologics Market Analysis, 2016 – 2026
6.3.1. Asia Pacific Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.3.2. Asia Pacific Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.3.3. Asia Pacific Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. India
6.3.3.4. Rest of Asia Pacific
6.4. Latin America Orthobiologics Market Analysis, 2016 – 2026
6.4.1. Latin America Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.4.2. Latin America Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.4.3. Latin America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa Orthobiologics Market, 2016 – 2026
6.5.1. Middle East & Africa Orthobiologics Market, by Product Type, 2016 - 2026 (US$ Mn)
6.5.2. Middle East & Africa Orthobiologics Market, by Application, 2016 - 2026 (US$ Mn)
6.5.3. Middle East & Africa Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. Depuy Synthes (A Subsidiary of Johnson & Johnson)
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Arthrex Inc.
7.3. Bioventus LLC
7.4. Globus Medical Inc.
7.5. Harvest Technologies Corporation (A Terumo Bct Company)
7.6. K2M Group Holdings Inc.
7.7. Kuros Biosciences Ltd.
7.8. Medtronic PLC
7.9. Nuvasive Inc.
7.10. Orthofix International NV
7.11. RTI Surgical Inc.
7.12. Stryker Corporation
7.13. Zimmer Biomet
7.14. Seaspine Holdings Corporation

Note:

Modification in the list of company profiles or scope of the study can be incorporated on request.

FIG 1. Orthobiologics Market: Research Methodology
FIG 2. Orthobiologics: Market Segmentation
FIG 3. Global Orthobiologics Market, by Product Type, 2017 (US$ Mn)
FIG 4. Global Orthobiologics Market, by Application Type, 2017 (US$ Mn)
FIG 5. Global Orthobiologics Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global Orthobiologics Market, by Key Players, 2017
FIG 8. Global Viscosupplementation Products Market, 2016-2026 (US$ Mn)
FIG 9. Global Demineralized Bone Matrices Market, 2016-2026(US$ Mn)
FIG 10. Global Synthetic Orthobiologics Market, 2016-2026(US$ Mn)
FIG 11. Global Bone Morphogenic Protein Market, 2016-2026(US$ Mn)
FIG 12. Global Allografts Market, 2016-2026(US$ Mn)
FIG 13. Global Plasma-Rich Protein Market, 2016-2026(US$ Mn)
FIG 14. Global Bone Marrow Aspirate Concentrate Market, 2016-2026(US$ Mn)
FIG 15. Global Orthobiologics Market for Osteoarthritis and Degenerative Arthritis, 2016-2026 (US$ Mn)
FIG 16. Global Orthobiologics Market for Spinal Fusion, 2016-2026(US$ Mn)
FIG 17. Global Orthobiologics Market for Soft-Tissue Injuries, 2016-2026 (US$ Mn)
FIG 18. Global Orthobiologics Market for Fracture Recovery, 2016-2026 (US$ Mn)
FIG 19. Global Orthobiologics Market for Maxillofacial and Dental Applications, 2016-2026 (US$ Mn)
FIG 20. U.S. Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 21. Canada Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 22. U.K. Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 23. Germany Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 24. Rest of Europe Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 25. China Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 26. Japan Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 27. South Korea Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 28. Rest of Asia Pacific Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 29. Brazil Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 30. Mexico Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 31. Rest of Latin America Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 32. GCC Orthobiologics Market, 2016-2026 (US$ Mn)
FIG 33. Rest of Middle East & Africa Orthobiologics Market, 2016-2026 (US$ Mn)

TABLE 1 Global Orthobiologics Market Portraiture
TABLE 2 Global Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global Orthobiologics Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America Orthobiologics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Orthobiologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Orthobiologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Orthobiologics Market, by Application Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Orthobiologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East & Africa Orthobiologics Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East & Africa Orthobiologics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa Orthobiologics Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 Depuy Synthes (A Subsidiary of Johnson & Johnson): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Arthrex Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Bioventus LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Globus Medical Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Harvest Technologies Corporation (A Terumo Bct Company): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 K2M Group Holdings Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Kuros Biosciences Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Medtronic PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Nuvasive Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Orthofix International NV: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 RTI Surgical Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Stryker Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Zimmer Biomet: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Seaspine Holdings Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients